Sponsor or institution
Clinical trials and research at SANGMYUNG innovation
As of November 12, 2026, Find a Trial lists 2 clinical trials run by SANGMYUNG innovation that are recruiting, in South Korea. By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
SMO1 vs reference dexamethasone implant for retinal vein occlusion with macular edema
This trial tests SMO1, a dexamethasone implant, to see if it works as well as the standard implant in people with vein blockage-related macular swelling in the eye.
-
SMZ1 plus ranibizumab vs placebo plus ranibizumab for wet AMD without PCV
A study tests whether SMZ1 tablets added to ranibizumab can give better vision improvement than placebo with ranibizumab in people 50 and older with a specific form of wet age-related macular degeneration.
Quick answers
How many clinical trials run by SANGMYUNG innovation are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.